Insider Trading Alert - MAIN, HCN And ROLL Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, June 24, 2015, 52 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $413.20 to $16,048,500.00.

Highlighted Stocks Traded by Insiders:

Main Street Capital Corporation (MAIN) - FREE Research Report

Canon Joseph E, who is Director at Main Street Capital Corporation, bought 191 shares at $31.65 on June 24, 2015. Following this transaction, the Director owned 44,981 shares meaning that the stake was boosted by 0.43% with the 191-share transaction.

Appling Michael JR, who is Director at Main Street Capital Corporation, bought 521 shares at $31.65 on June 24, 2015. Following this transaction, the Director owned 95,893 shares meaning that the stake was boosted by 0.55% with the 521-share transaction.

Griffin Jon Kevin, who is Director at Main Street Capital Corporation, bought 80 shares at $31.65 on June 24, 2015. Following this transaction, the Director owned 16,309 shares meaning that the stake was boosted by 0.49% with the 80-share transaction.

The shares most recently traded at $32.32, up $0.67, or 2.07% since the insider transaction. Historical insider transactions for Main Street Capital Corporation go as follows:

  • 4-Week # shares bought: 2,500
  • 12-Week # shares bought: 2,500
  • 24-Week # shares bought: 2,500

The average volume for Main Street Capital Corporation has been 174,300 shares per day over the past 30 days. Main Street Capital Corporation has a market cap of $1.6 billion and is part of the financial sector and financial services industry. Shares are up 9.44% year-to-date as of the close of trading on Wednesday.

Main Street Capital Corporation is a business development company specializing in long- term equity and debt investments in small and lower middle market companies. The stock currently has a dividend yield of 6.56%. The company has a P/E ratio of 15.2. Currently, there are 3 analysts who rate Main Street Capital Corporation a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MAIN - FREE

TheStreet Quant Ratings rates Main Street Capital Corporation as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, increase in net income and expanding profit margins. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Main Street Capital Corporation Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Health Care REIT (HCN) - FREE Research Report

Ibele Erin C, who is EVP-Head Human Cap.&Corp.Secy. at Health Care REIT, sold 550 shares at $68.54 on June 24, 2015. Following this transaction, the EVP-Head Human Cap.&Corp.Secy. owned 52,720 shares meaning that the stake was reduced by 1.03% with the 550-share transaction.

The shares most recently traded at $66.02, down $2.52, or 3.81% since the insider transaction. Historical insider transactions for Health Care REIT go as follows:

  • 4-Week # shares bought: 2,400
  • 4-Week # shares sold: 1,533
  • 12-Week # shares bought: 2,400
  • 12-Week # shares sold: 5,699
  • 24-Week # shares bought: 2,400
  • 24-Week # shares sold: 22,938

The average volume for Health Care REIT has been 2.0 million shares per day over the past 30 days. Health Care REIT has a market cap of $23.5 billion and is part of the financial sector and real estate industry. Shares are down 11.42% year-to-date as of the close of trading on Wednesday.

Health Care REIT, Inc. is an independent equity real estate investment trust. The firm engages in acquiring, planning, developing, managing, repositioning and monetizing of real estate assets. It primarily invests in the real estate markets of the United States. The stock currently has a dividend yield of 4.92%. The company has a P/E ratio of 36.8. Currently, there are 6 analysts who rate Health Care REIT a buy, 1 analyst rates it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HCN - FREE

TheStreet Quant Ratings rates Health Care REIT as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and reasonable valuation levels. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full Health Care REIT Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

RBC Bearings (ROLL) - FREE Research Report

OBrien Thomas J, who is Director at RBC Bearings, sold 2,000 shares at $73.00 on June 24, 2015. Following this transaction, the Director owned 12,250 shares meaning that the stake was reduced by 14.04% with the 2,000-share transaction.

The shares most recently traded at $72.01, down $0.99, or 1.37% since the insider transaction. Historical insider transactions for RBC Bearings go as follows:

  • 4-Week # shares bought: 2,000
  • 4-Week # shares sold: 10,273
  • 12-Week # shares bought: 2,000
  • 12-Week # shares sold: 10,273
  • 24-Week # shares bought: 2,000
  • 24-Week # shares sold: 10,273

The average volume for RBC Bearings has been 89,000 shares per day over the past 30 days. RBC Bearings has a market cap of $1.7 billion and is part of the industrial goods sector and industrial industry. Shares are up 13.44% year-to-date as of the close of trading on Wednesday.

RBC Bearings Incorporated manufactures and markets precision plain, roller, and ball bearings primarily in North America, Europe, Asia, and Latin America. It operates in four segments: Plain Bearings, Roller Bearings, Ball Bearings, and Other. The company has a P/E ratio of 32.5. Currently, there are 3 analysts who rate RBC Bearings a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ROLL - FREE

TheStreet Quant Ratings rates RBC Bearings as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, expanding profit margins and solid stock price performance. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full RBC Bearings Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you liked this article you might like

9 Banking Bets, From Main Street to Wall Street

9 Banking Bets, From Main Street to Wall Street

What's Hot and What's Not: Cramer's 'Mad Money' Recap (Thursday 10/12/17)

What's Hot and What's Not: Cramer's 'Mad Money' Recap (Thursday 10/12/17)

10 Ideas for Generating Monthly Dividends

10 Ideas for Generating Monthly Dividends

This Stock Has an Exceptional Dividend Yield of Over 10%

This Stock Has an Exceptional Dividend Yield of Over 10%

Move Over, REITs; BDCs Aren't Afraid of Increasing Interest Rates

Move Over, REITs; BDCs Aren't Afraid of Increasing Interest Rates